Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127180101 | 12718010 | 1 | I | 20160810 | 20160829 | 20160906 | 20160906 | EXP | IL-SA-2016SA163808 | AVENTIS | 71.00 | YR | E | F | Y | 46.00000 | KG | 20160906 | MD | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127180101 | 12718010 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | Y | UNK | 20839 | 75 | MG | QD | ||||||
| 127180101 | 12718010 | 2 | SS | APIXABAN | APIXABAN | 1 | Oral | Y | UNK | 0 | 10 | MG | QD | ||||||
| 127180101 | 12718010 | 3 | SS | INVESTIGATIONAL DRUG | INVESTIGATIONAL PRODUCT | 1 | Oral | Y | UNK | 0 | 81 | MG | QD | ||||||
| 127180101 | 12718010 | 4 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 5 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 8 | C | CLONIDINE. | CLONIDINE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 9 | C | CANDESARTAN | CANDESARTAN | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 10 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 11 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 12 | C | GLIBENCLAMIDE | GLYBURIDE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 14 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 15 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 16 | C | BROTIZOLAM | BROTIZOLAM | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 17 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 18 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 127180101 | 12718010 | 19 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127180101 | 12718010 | OT |
| 127180101 | 12718010 | HO |
| 127180101 | 12718010 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127180101 | 12718010 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127180101 | 12718010 | 1 | 20160704 | 20160810 | 0 | |
| 127180101 | 12718010 | 2 | 20160704 | 20160810 | 0 | |
| 127180101 | 12718010 | 3 | 20160802 | 20160810 | 0 | |
| 127180101 | 12718010 | 4 | 20160705 | 0 | ||
| 127180101 | 12718010 | 5 | 201412 | 20160704 | 0 | |
| 127180101 | 12718010 | 6 | 20160705 | 0 | ||
| 127180101 | 12718010 | 7 | 2005 | 20160630 | 0 | |
| 127180101 | 12718010 | 8 | 20160629 | 0 | ||
| 127180101 | 12718010 | 9 | 20160630 | 0 | ||
| 127180101 | 12718010 | 10 | 20160630 | 0 | ||
| 127180101 | 12718010 | 11 | 20160701 | 20160701 | 0 | |
| 127180101 | 12718010 | 12 | 201508 | 0 | ||
| 127180101 | 12718010 | 13 | 201412 | 0 | ||
| 127180101 | 12718010 | 14 | 2003 | 0 | ||
| 127180101 | 12718010 | 15 | 2010 | 0 | ||
| 127180101 | 12718010 | 16 | 2012 | 0 |